Industry supported sessions

Industry supported sessions

SATURDAY, 02 NOVEMBER 2019

​11:30 - 12:50
Plenary Hall Washington A
11:30 - 12:50​





11:30 - 12:00










12:00 - 12:20










12:20 - 12:50
Non-CME Industry session
(not included in the main event CME/CPD credit offering)

Chair:
Samuli RautavaUniversity of Turku, Finland

  • Prevention of Mastitis by Oral Administration of Lactobacillus Salivarius PS2 during Late Pregnancy and Early Lactation
     Juan Miguel Rodriguez
     University Complutense Madrid, Spain
     Danone Nutricia Research
Danone-Nutricia-Research (1).jpg
 
  • Improving the accuracy and reproducibility of microbiome measurements across labs
       Irma Ochigava
       Zymo Research Europe GmbH, Germany
Zymo logo_cmyk_Hintergrundlos.png


  • Human milk oligosaccharides (HMOs) – nature´s prebiotic for a healthy gut microbiome

       Hue Tran Hornig-Do

      Jennewein Biotechnologie Germany

Jennewein_Logo.BMP



PRODUCT THEATRE

friday, 01 november 2019


​Exhibition & Networking Area Le Baron
​10:40 - 10:50
  • ​Launch of the 1st* food supplement with HMOs** within Biostime probiotics range
      Virginie Beraud, Biostime, Switzerland 

Biostime, brand specialized in infant nutrition, and number 1 of kids supplements with probiotics in the world*, is launching is new innovative product on the French market : Biostime probiotics with HMOs**.
This unique product combines 4 probiotic strains and 2'-fucosyllactose, the most abundant oligosaccharide in human milk. 
This presentation will give an overview of Biostime probiotics range with a focus on this innovation and the exciting science that has been developed around it.

*In the French market, September 2019

**Human Milk Oligosaccharides 

​16:00 - 16:10
  • ​Unlocking The Microbiome with Strain-Level Metagenomics
      Arne MaternaCosmosID, USA

CosmosID has been an industry leader in high-resolution metagenomic since 2008 and addresses key bottlenecks in microbiome shotgun sequencing such as limitations inherent to non-standardized NGS workflows and the databases, algorithms and computational infrastructure required for accurate and actionable bioinformatic analysis. In response to these challenges, CosmosID leverages 10 years of focused R&D in microbial genomics and metagenomics to deliver the world's most advanced microbiome analysis platform; returning strain-level resolution of bacteria, viruses, fungi, protists, AMR & Virulence factors, with industry-leading sensitivity & precision.


SATURDAY, 02 NOVEMBER 2019


​Exhibition & Networking Area Le Baron
​10:25 - 10:35
  • ​Еarly Life Development of the Canine Gut Microbiota
      David Wrigglesworth,

As reported in human studies, the initial establishment of the canine gut microbiota is an essential step in neonatal development; influencing immunological development in infancy, and health throughout life. Understanding changes in the neonatal microbiota may provide insights into the microbial species able to colonise the canine gut, providing the opportunity to facilitate the early colonisation of the gut in a manner that promotes the long-term health of the host. We describe the developing puppy microbiota prior to weaning, and the changes observed following weaning from 24 days of age. Data are presented from two cohorts, differing in both maternal and puppy weaning diets, consisting of six and nine litters respectively.  In both cases, the puppy faecal microbiota experienced rapid transformations following weaning onto dry kibble commercial puppy food. Further, similarities in relative abundance of taxa between the cohorts were also observed at the taxonomic level of genus and species. The commonality seen between the two cohorts suggests that patterns of bacterial colonisation of the canine gut in early life may be conserved and points to a period of rapid maturation or development in the gut microbiome, associated with weaning and placement in new environments at homing.  These data describe an early characterisation of the microbiota during the period associated with immune priming and gastrointestinal maturation in new-born puppies. Similar to the human infant, the process of weaning and environment appear to represent major influences on the microbiota in early life. However, the insights gained suggest differences in the microbiota of puppies compared to human infants that may provide opportunities for specific nutritional interventions for the microbiome in puppies and dogs as they develop.